Human stable cell line ETV6-NTRK2. A cell line called BaF3 has been modified to express the fusion gene ETV6-NTRK2. The transcription factor ETS family with two functional domains—a C-terminal DNA-binding domain and an N-terminal pointed (PNT) domain involved in protein-protein interactions—is encoded by ETV6, sometimes referred to as ETS variant transcription factor 6. Its significance in hematopoiesis and vascular network development is suggested by knockout experiments conducted in mice. It is also known to be involved in chromosomal rearrangements linked to congenital fibrosarcoma and leukemia.
The neurotrophic tyrosine receptor kinase 2 (NTRK2) is a member of the neurotrophic tyrosine receptor kinase family. It encodes a membrane-bound receptor that triggers cell differentiation through neurotrophin signaling. Obesity and mental problems have been linked to mutations in NTRK2. Obesity and mental problems have been linked to mutations in NTRK2. NTRK2 is activated, homodimerizes, and becomes autophosphorylated upon binding neurotrophin. This process attracts downstream effectors, including PLCG1, FRS2, SH2B1, and SH2B2, which modulate signaling cascades that govern neuron survival, proliferation, migration, and synaptic plasticity.
A popular mouse pro-B lymphoid cell line for researching hematopoietic growth factor signaling is called BaF3. These cells may be grown in media supplemented with interleukin-3 (IL-3), which they need for growth and survival. BaF3 cells are useful for examining the signaling pathways and carcinogenic potential of fusion genes such as ETV6-NTRK2.
Next-generation sequencing (NGS) for the detection of molecular changes has advanced as a result of targeted therapy in conjunction with companion diagnostics. To detect NTRK1, NTRK2, NTRK3, ROS1, and ALK rearrangements in formalin-fixed paraffin-embedded clinical tissues, the researchers have created a two-step diagnostic technique. To identify samples expressing TrkA, TrkB, TrkC, ROS1, and ALK, this test employs pan-receptor tyrosine kinase cocktail immunohistochemistry screening. An RNA-based anchored multiplex polymerase chain reaction NGS assay is performed on positive samples. Gene rearrangements can be reliably and accurately identified using the NGS assay. The confidence in negative NGS results is ensured by implementing an RNA quality control metric. With a 100% negative predictive value, the pan-receptor tyrosine kinase labeling raises the detection rate of gene rearrangements from 4% to 9%.
Figure 1. To investigate gene rearrangements, the scientists prepared FFPE specimens from cell pellets embedded in agarose at densities of 100–200 million cells, using the ETV6-NTRK2 stable cell line (BaF3). The researchers utilized the ETV6-NTRK2 Stable Cell Line - BaF3 to investigate gene rearrangements using NGS assays, examining median unique RNA reads for receptors like NTRK1, NTRK2, NTRK3, ROS1, and ALK. (Murphy DA, et al., 2017)
1. Cancer research: Using the human ETV6-NTRK2 stable cell line Ba/F3, we study the role of this fusion gene in congenital fibrosarcoma and leukemia, reveal its molecular mechanism in the occurrence and development of cancer, and provide basic data for new treatment options.
2. Signal transduction research: Through the ETV6-NTRK2 cell model, explore its signal transduction pathways in cell differentiation and proliferation, including the response to neurotrophic factor signals, and reveal its role in neuronal survival and synaptic plasticity.
3. Drug screening and evaluation: Using the efficient transgenic ability of Ba/F3 cells, screen and evaluate targeted drugs targeting the ETV6-NTRK2 fusion gene, study its potential efficacy in cancer and neurological diseases, and promote drug development.
4. Genetic disease research: By studying the role of NTRK2 mutations in obesity and mental illness, using ETV6-NTRK2 stable cell lines, reveal how these mutations affect neuronal function and behavior, and develop related treatment strategies.
5. Hematopoiesis and angiogenesis research: Using the ETV6-NTRK2 cell model, explore the role of the ETV6 gene in hematopoiesis and vascular network development, understand its function in related diseases, and provide new ideas for the treatment of blood diseases and vascular lesions.
Customer Q&As
How pure is this human ETV6-NTRK2 stable cell line? Is there any possibility of hybridization or mutation?
A: Our human ETV6-NTRK2 stable cell line has undergone rigorous purification and validation procedures to ensure its purity and stability. We use a variety of techniques to identify cell lines, including PCR, immunofluorescence staining, and Western blot. We also regularly perform cytological testing of cell lines to ensure they are free of hybridization or mutation.
When studying the role of ETV6-NTRK2 in leukemogenesis, what is the expression level of this stable cell line? Is relevant experimental data support provided?
A: Our human ETV6-NTRK2 stable cell line has stable expression levels and has been widely used in research on the mechanisms of leukemia. We provide detailed experimental data support, including Western blot analysis, flow cytometry, etc. Customers can refer to these data to evaluate the performance of our products.
Is this human ETV6-NTRK2 stable cell line suitable for new drug development experiments? Is there relevant literature support?
A: Our human ETV6-NTRK2 stable cell line has been used in new drug development experiments. We provide relevant literature support demonstrating the application potential of our products in these areas. Customers can refer to these documents to understand the performance and application range of our products.
Ask a Question
Customer Reviews
Professional service
I would like to commend the supplier for the professional service they provided. Their expertise on the product was impressive and they gave me detailed answers to my questions, which gave me a clearer understanding of the product.
Stability
I am very pleased with the stability of the cell line. During the culture process, I observed healthy cell growth and stable gene expression, which provided reliable data support for my experimental results. Overall, I am very satisfied with the quality and service of this product and look forward to more cooperation opportunities in the future.
Reliable support
My experience with the Human ETV6-NTRK2 stable cell line has been excellent. They were knowledgeable about the product and were able to provide timely and effective support, making my research progress smoothly. I am also very pleased with the stability of the cell line. During the culture process, I observed stable cell growth and consistent gene expression, which provided reliable experimental data for my research.
Write a Review